CLINICAL_TRIALS
trial_result
· 2019-09-19
Clinical Trial Update: Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL [Phase 1]
Summary
Phase 1 trial evaluating dimethylfumarate in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma; study terminated with results post…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Michael Choi | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2019-09-19